Controlled Clinical TrialiVNSn = 31

Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device

Camilleri M, Toouli J, Herrera MF, Kulseng B, Kow L, Pantoja JP, Marvik R, Johnsen G, Billington CJ, Moody FG, et al.

Surgery · 2008

Key finding

In this open-label feasibility study, 31 obese subjects implanted with intermittent intra-abdominal vagal blockade achieved a mean excess weight loss of 14.2% at 6 months with reduced appetite and caloric intake.

Condition
Obesity
Stimulation
iVNS
Evidence tier
Controlled Clinical Trial
Participants
31
View on DOI

Cite this study

Camilleri, M., Toouli, J., Herrera, M. F., Kulseng, B., Kow, L., Pantoja, J. P., Marvik, R., Johnsen, G., Billington, C. J., Moody, F. G., Knudson, M. B., Tweden, K. S., Vollmer, M., Wilson, R. R., & Anvari, M. (2008). Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. Surgery, 143(6), 723-731. https://doi.org/10.1016/j.surg.2008.03.015

Related studies in Obesity

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.